However, an investigation carried out by Pan et al. [43] indicated that upregulation of p62 correlates with lesser sorafenib sensitivity in HepG2 cells, being also linked to a worse HCC prognosis [44]. Here, SQSTM1 is linked to hepatocellular carcinoma.